Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sudarshan Pharma IndustriesBOM:543828 -5.00%69 Current Ratio is 1.07 as of Mar. 2026, which is 16% below its 10-year median of 1.28. GuruFocus rates BOM:543828 with a GF Score™ of 69/100 and a GF Value™ of ₹6.52 (Significantly Overvalued). The stock has 14 warning signs investors should review. Among 1,606 Chemicals companies, Sudarshan Pharma Industries ranks worse than 82.57% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Sudarshan Pharma Industries's current ratio for the quarter that ended in Mar. 2026 was 1.07.
Sudarshan Pharma Industries has a current ratio of 1.07. It generally indicates good short-term financial strength.
The historical rank and industry rank for Sudarshan Pharma Industries's Current Ratio or its related term are showing as below:
BOM:543828'
s Current Ratio Range Over the Past 10 Years
Min: 1.07 Med: 1.28 Max: 1.68
Current: 1.07
During the past 10 years, Sudarshan Pharma Industries's highest Current Ratio was 1.68. The lowest was 1.07. And the median was 1.28.
BOM:543828's Current Ratio is ranked worse than 82.57% of 1606
companies
in the Chemicals industry
Industry Median: 1.87
vs BOM:543828: 1.07
Sudarshan Pharma Industries (BOM:543828) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Sudarshan Pharma Industries Current Ratio Related Terms
Sudarshan Pharma Industries Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Sudarshan Pharma Industries's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sudarshan Pharma Industries Current Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Sudarshan Pharma Industries's Current Ratio distribution charts can be found below:
* The bar in red indicates where Sudarshan Pharma Industries's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sudarshan Pharma Industries (BOM:543828) has a Current Ratio of 1.07 as of Mar. 2026. This is 16% below median its historical median of 1.28. Over the past decade, Sudarshan Pharma Industries' Current Ratio has ranged from 1.07 to 1.68. According to the industry distribution chart, Sudarshan Pharma Industries ranks #1326 out of 1606 companies in the Chemicals industry, placing it in the top 82.6%.
Is Sudarshan Pharma Industries' Current Ratio too high?
Sudarshan Pharma Industries' current Current Ratio of 1.07 is 16% below median its 10-year median of 1.28. Over the past 10 years, this metric has ranged from a low of 1.07 to a high of 1.68. The Chemicals industry median Current Ratio is 1.87. Sudarshan Pharma Industries' value of 1.07 is 42.8% below this industry median. Based on the distribution chart, Sudarshan Pharma Industries ranks #1326 out of 1606 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Sudarshan Pharma Industries has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sudarshan Pharma Industries' Current Ratio compare to DOW?
According to the Chemicals industry distribution chart, Sudarshan Pharma Industries ranks #1326 out of 1606 companies for Current Ratio. This places Sudarshan Pharma Industries in the lower half of its industry. The industry median Current Ratio is 1.87. Sudarshan Pharma Industries' value of 1.07 is 42.8% below this benchmark. Historically, Sudarshan Pharma Industries' own Current Ratio has ranged from 1.07 to 1.68 over the past decade. While the company's 10-year median is 1.28 vs. the industry median of 1.87, Sudarshan Pharma Industries has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Chemicals company?
The median Current Ratio among Chemicals companies is 1.87, based on 1,606 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sudarshan Pharma Industries's current Current Ratio of 1.07 is 42.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Chemicals industry, the median Current Ratio is 1.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sudarshan Pharma Industries's current Current Ratio is 1.07, which is 16% below median its own 10-year median of 1.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sudarshan Pharma Industries stock overvalued right now?
Based on GuruFocus' analysis, Sudarshan Pharma Industries (BOM:543828) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹6.52, compared to a current price of ₹32.49 — trading 398.3% above its estimated fair value. The current Current Ratio is 1.07, which is 16% below median its 10-year median of 1.28 and 42.8% below the Chemicals industry median of 1.87. Sudarshan Pharma Industries' overall GF Score™ is 69/100 with 14 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Sudarshan Pharma Industries (BOM:543828), the current Current Ratio is 1.07 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sudarshan Pharma Industries (BOM:543828) Overvalued in 2026?
Based on GuruFocus' analysis, Sudarshan Pharma Industries stock appears to be overvalued.
The current stock price of ₹32.49 is trading 398.3% above its estimated GF Value™ of ₹6.52.
GuruFocus considers Sudarshan Pharma Industries to be Significantly Overvalued.
Key valuation signals for BOM:543828:
Current Ratio: 1.07 (16% below median its 10-year median of 1.28)
GF Value™: ₹6.52 vs. price of ₹32.49 (398.3% above fair value)
Industry Position: 42.8% below the Chemicals median (#1326 of 1606)
No single metric tells the full story. See the BOM:543828 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sudarshan Pharma Industries Ltd operates in the pharmaceutical and chemical industries, focusing on specialty chemicals and intermediates used in pharmaceuticals, paints, food products, and adhesives. The Company has a presence domestically and internationally, participating regularly in trade fairs and exhibitions. The Company exports mainly to South East Asia, the Middle East, and North Africa. The Company also supplies generic pharmaceutical formulation as 'Make to order' for bulk supply to hospitals and related healthcare organisations. The company has one reportable segment of Specialty Chemicals.
69GF Score
Get the complete analysis for BOM:543828
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543828 has been successfully added to your 
